Annual Drug Patent Expirations for MEKINIST
Mekinist is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug.
This drug has ninety-nine patent family members in forty-two countries.
The generic ingredient in MEKINIST is trametinib dimethyl sulfoxide. One supplier is listed for this compound. Additional details are available on the trametinib dimethyl sulfoxide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com